Glancy Prongay Seeks To Represent Blood Clot Co. Investors
By Emilie Ruscoe ( March 17, 2020, 8:02 PM EDT) -- Glancy Prongay & Murray LLP on Monday sought to represent a proposed class of investors in a proposed securities fraud class action accusing biotechnology company Portola Pharmaceuticals Inc. of not properly explaining how changes related to its product reserves would affect its bottom line....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.